(Q41630631)

English

Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses.

scientific article published on 30 October 2014

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Nasal immunization of mice with AFCo1 or AFPL1 plus capsular polysaccharide Vi from Salmonella typhi induces cellular response and memory B and T cell responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

based on heuristic

inferred from title

Salmonella typhi

object named as

Salmonella typhi

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Miriam Lastre

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Laura Reyes

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Elizabeth González

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Yusnaby Borrero

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Diandra Lescaille

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Rocmira Pérez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Darzy Nuñez

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Oliver Pérez

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

language of work or name

0 references

publication date

30 October 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

51

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6971-6978

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25454865%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Key roles of adjuvants in modern vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immune response induction and new effector mechanisms possibly involved in protection conferred by the Cuban anti-meningococcal BC vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

New vaccines require potent adjuvants like AFPL1 and AFCo1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Can successful vaccines teach us how to induce efficient protective immune responses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Development of Vi conjugate - a new generation of typhoid vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Combined meningococcal serogroup A and W135 outer-membrane vesicles activate cell-mediated immunity and long-term memory responses against non-covalent capsular polysaccharide A.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The capsular polysaccharide Vi from Salmonella typhi is a B1b antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Hypothesis for vaccine development: protective immunity to enteric diseases caused by nontyphoidal salmonellae and shigellae may be conferred by serum IgG antibodies to the O-specific polysaccharide of their lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar Typhi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The advantage of mucosal immunization for polysaccharide-specific memory responses in early life.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Pneumococcal polysaccharide abrogates conjugate-induced germinal center reaction and depletes antibody secreting cell pool, causing hyporesponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Role of capsular polysaccharide in Group B Streptococccus interactions with dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Targeting immune response induction with cochleate and liposome-based vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Immune adjuvant effect of V. cholerae O1 derived Proteoliposome coadministered by intranasal route with Vi polysaccharide from Salmonella Typhi

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

The thymus-independent immunity conferred by a pneumococcal polysaccharide is mediated by long-lived plasma cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

What is and what should always have been: long-lived plasma cells induced by T cell-independent antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

T cell-independent B cell memory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Toll-like receptor agonists allow generation of long-lasting antipneumococcal humoral immunity in response to a plain polysaccharidic vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Long-term maintenance of polysaccharide-specific antibodies by IgM-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Mucosal clearance of capsule-expressing bacteria requires both TLR and nucleotide-binding oligomerization domain 1 signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2014.10.037

7 January 2021

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41630631&oldid=1799636984"